ILMN Live signals | Maximize Profits with Getagraph.com

SELL 262 min ago

@ $105.50

Issued: 1 Jul 2024 @ 15:35

Return: 0.00%

Previous signal: Jul 1 - 10:44

Previous signal: Buy

Return: 0.50 %

Live Chart Being Loaded With Signals

Commentary (1 Jul 2024 @ 16:00):
Our systems believe the stock currently is undervalued by 0.01% compare to its pairs and should correct upwards.

Stats
Today's Volume	1.75M
Average Volume	2.68M
Market Cap	16.81B
EPS	$-0.790 ( Q1 \| 2024-05-03 )
Next earnings date	( $0.110 ) 2024-08-14
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-12.94 (Sector) 42.63 (Industry) 0
ATR14	$4.86 (4.60%)

ACRS 4.55%

AKU -17.87%

APDN 33.45%

BDSX 0.00%

BIOC 0.00%

BNGO -2.32%

BNR -0.16%

CDNA -0.97%

CEMI 0.22%

CHEK 3.03%

CNTG 2.73%

CSTL -2.66%

DMTK -11.32%

DRIO -1.68%

EXAS 0.43%

FLDM -7.02%

FLGT 2.14%

GENE -5.37%

GH -2.15%

GTH 0.12%

HTGM 0.00%

ICLR 0.97%

IDXX -2.22%

ILMN 1.07%

ISPC -1.91%

LAB -2.26%

LMDX 0.00%

MDXH -1.26%

ME -3.83%

MEDP -1.12%

MYGN -2.00%

MYNZ -13.92%

NDRA -4.43%

NEO 0.43%

NEOG -3.77%

NOTV -4.22%

NTRA -0.44%

OCDX 0.92%

OLK 0.27%

OPGN -2.98%

OPK -1.60%

PMD -2.89%

PRPO 6.01%

PSNL 2.14%

RDNT -0.63%

SERA 2.03%

SHC -2.44%

SQL 0.00%

STIM -2.78%

STRR -3.52%

STRRP -6.57%

SYNH 0.02%

TRIB 6.28%

TTOO 0.75%

TWST -0.71%

VIVO 0.00%

XGN -0.55%

Insider Trading

Date	Person	Action	Amount	type
2024-06-28	Ullem Scott B.	Buy	205	Common Stock
2024-06-10	Cunningham Everett	Buy	0	Common Stock
2024-06-10	Cunningham Everett	Buy	0	Common Stock
2024-06-10	Cunningham Everett	Buy	0	Common Stock
2024-06-10	Cunningham Everett	Buy	0	Common Stock

INSIDER POWER
83.91
Last 93 transactions
Buy: 263 924 \| Sell: 31 066

Correlation (AI algo v.1.1b): Undervalued: 0.01% $105.57 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Volume Correlation

Long: 0.66 (moderate)

Short: -0.24 (neutral)

Signal:(55) Neutral

Illumina Inc Correlation

10 Most Positive Correlations
MBIO	0.894
APDN	0.878
SAGE	0.867
MPAA	0.865
JACK	0.865
VRSN	0.864
FAIL	0.864
INTZ	0.862
LSXMK	0.86
ASNS	0.86

10 Most Negative Correlations
NKTR	-0.912
SMTC	-0.908
RVMD	-0.902
VERU	-0.901
AEYE	-0.9
USAP	-0.897
QRHC	-0.896
SGMA	-0.885
SLAM	-0.884
BNTC	-0.884

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Illumina Inc Correlation - Currency/Commodity

-0.48
( neutral )

-0.51
( weak negative )

0.00
( neutral )

0.09
( neutral )

0.41
( neutral )

-0.29
( neutral )

Illumina Inc Financials

Annual	2023
Revenue:	$4.50B
Gross Profit:	$2.75B (61.06 %)
EPS:	$-7.35

FY	2023
Revenue:	$4.50B
Gross Profit:	$2.75B (61.06 %)
EPS:	$-7.35

FY	2022
Revenue:	$4.58B
Gross Profit:	$2.97B (64.83 %)
EPS:	$-28.05

FY	2021
Revenue:	$4.53B
Gross Profit:	$3.15B (69.69 %)
EPS:	$5.07

Financial Reports:

No articles found.

Illumina Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Illumina Inc

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as cancer detection testing services. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The company was incorporated in 1998 and is based in San Diego, California.